Jensen FC - Search Results

1

Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells.

Trauger RJ, Ferre F, Daigle AE, Jensen FC, Moss RB, Mueller SH, Richieri SP, Slade HB, Carlo DJ. Trauger RJ, et al. Among authors: jensen fc. J Infect Dis. 1994 Jun;169(6):1256-64. doi: 10.1093/infdis/169.6.1256. J Infect Dis. 1994. PMID: 7910836 Clinical Trial.

2

Maternal and newborn immunization with a human immunodeficiency virus-1 immunogen in a rodent model.

Moss RB, Savary JR, Diveley JP, Jensen F, Carlo DJ. Moss RB, et al. Immunology. 2002 Aug;106(4):549-53. doi: 10.1046/j.1365-2567.2002.01464.x. Immunology. 2002. PMID: 12153518 Free PMC article.

3

Viral load in peripheral blood mononuclear cells as surrogate for clinical progression.

Ferre F, Moss RB, Daigle A, Richieri SP, Jensen F, Carlo DJ. Ferre F, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 2:S51-6. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552513 Review.

4

Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial.

Trauger RJ, Daigle AE, Giermakowska W, Moss RB, Jensen F, Carlo DJ. Trauger RJ, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 2:S74-82. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552517 Clinical Trial.

5

Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography.

Richieri SP, Bartholomew R, Aloia RC, Savary J, Gore R, Holt J, Ferre F, Musil R, Tian HR, Trauger R, Lowry P, Jensen F, Carlo DJ, Maigetter RZ, Prior CP. Richieri SP, et al. Vaccine. 1998 Jan-Feb;16(2-3):119-29. doi: 10.1016/s0264-410x(97)00196-5. Vaccine. 1998. PMID: 9607019

6

In vitro immune function after vaccination with an inactivated, gp120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotides.

Moss RB, Diveley J, Jensen F, Carlo DJ. Moss RB, et al. Vaccine. 2000 Jan 6;18(11-12):1081-7. doi: 10.1016/s0264-410x(99)00368-0. Vaccine. 2000. PMID: 10590329

7

T-helper-cell proliferative responses to whole-killed human immunodeficiency virus type 1 (HIV-1) and p24 antigens of different clades in HIV-1-infected subjects vaccinated with HIV-1 immunogen (Remune).

Moss RB, Giermakowska W, Wallace MR, Savary J, Jensen F, Carlo DJ. Moss RB, et al. Clin Diagn Lab Immunol. 2000 Sep;7(5):724-7. doi: 10.1128/CDLI.7.5.724-727.2000. Clin Diagn Lab Immunol. 2000. PMID: 10973444 Free PMC article.

8

Autoproliferation in HIV-1-infected patients undergoing active HIV-1-specific immunotherapy.

Trauger RJ, Giermakowska W, Wormsley S, Turner J, Jensen FC, Carlo DJ. Trauger RJ, et al. Among authors: jensen fc. Clin Exp Immunol. 1995 Apr;100(1):7-12. doi: 10.1111/j.1365-2249.1995.tb03596.x. Clin Exp Immunol. 1995. PMID: 7697926 Free PMC article. Clinical Trial.

9

Development and validation of a polymerase chain reaction method for the precise quantitation of HIV-1 DNA in blood cells from subjects undergoing a 1-year immunotherapeutic treatment.

Ferre F, Marchese AL, Griffin SL, Daigle AE, Richieri SP, Jensen FC, Carlo DJ. Ferre F, et al. Among authors: jensen fc. AIDS. 1993 Nov;7 Suppl 2:S21-7. doi: 10.1097/00002030-199311002-00006. AIDS. 1993. PMID: 8161442 Clinical Trial.

10

Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burden.

Trauger RJ, Giermakowska WK, Ferre F, Duffy PC, Wallace MR, Lewis DE, Beecham HJ, Burnett KG, Jensen FC, Carlo DJ. Trauger RJ, et al. Among authors: jensen fc. Immunology. 1993 Apr;78(4):611-5. Immunology. 1993. PMID: 8495981 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters